Lakefront Biotherapeutics (LKFT) Other Operating Expenses (2016 - 2026)
Lakefront Biotherapeutics (LKFT) posted quarterly Other Operating Expenses of $1.3 million for Q1 2026, down 81.73% year-over-year from $6.9 million in Q1 2025, and up 100.09% quarter-over-quarter from -$1.4 billion in Q4 2025.
Lakefront Biotherapeutics (LKFT) Other Operating Expenses (2016 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Other Operating Expenses for 11 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses fell 81.73% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at -$923.3 million (down 1197.42% YoY), while the FY2025 annual figure was $62.3 million, up 42.92% from the prior year.
- Other Operating Expenses improved to $1.3 million in Q1 2026 per LKFT's latest filing, from -$1.4 billion in the prior quarter.
- Across five years, Other Operating Expenses topped out at $432.6 million in Q3 2025 and bottomed at -$1.4 billion in Q4 2025.
- Historically, Other Operating Expenses has averaged -$43.6 million across 5 years, with a median of $10.2 million in 2024.
- On a YoY basis, Other Operating Expenses climbed as much as 1490.04% in 2025 and fell as far as 2369.31% in 2025.
- Lakefront Biotherapeutics' Other Operating Expenses stood at $6.8 million in 2022, then soared by 106.07% to $14.0 million in 2023, then surged by 329.36% to $60.1 million in 2024, then plunged by 2369.31% to -$1.4 billion in 2025, then surged by 100.09% to $1.3 million in 2026.
- Business Quant data shows LKFT's Other Operating Expenses at $1.3 million in Q1 2026, -$1.4 billion in Q4 2025, and $432.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lakefront Biotherapeutics | 1.81 Bn | -1.68 Bn | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | -1.36 Bn |
| Sep 30, 2025 | 432.64 Mn |
| Jun 30, 2025 | 5.67 Mn |
| Mar 31, 2025 | 6.94 Mn |
| Dec 31, 2024 | 60.06 Mn |
| Sep 30, 2024 | 27.21 Mn |
| Jun 30, 2024 | -10.07 Mn |
| Mar 31, 2024 | 10.20 Mn |
| Dec 31, 2023 | 13.99 Mn |
| Sep 30, 2023 | 13.77 Mn |
| Jun 30, 2023 | 14.66 Mn |
| Mar 31, 2023 | 7.34 Mn |
| Dec 31, 2022 | 6.79 Mn |
| Sep 30, 2022 | 11.97 Mn |
| Jun 30, 2022 | 10.59 Mn |
| Mar 31, 2022 | 8.62 Mn |
| Dec 31, 2021 | 11.18 Mn |
| Sep 30, 2021 | 42.81 Mn |
| Jun 30, 2021 | 16.02 Mn |